Saudi Medical Journal. 2009; 30 (2): 288-291
em Inglês
| IMEMR
| ID: emr-92639
ABSTRACT
Fetal valproate syndrome [FVS] is a well-recognized constellation of dysmorphic features, and neurodevelopmental retardation that results from prenatal exposure to the anticonvulsant valproic acid. In this report, we describe a case with typical features of FVS. A 23-year-old lady with post-traumatic epilepsy controlled by sodium valproate [Depakene] 500 mg twice daily throughout pregnancy as monotherapy, gave birth to a female baby with facial features characteristic of FVS, and severe radial ray reduction. She also had wide-spaced nipples and short neck, features not described before. Sodium valproate, a widely used anticonvulsant and mood regulator, is a well-recognized teratogen that can result in severe limb deformities, craniosynostosis, neural tube defects and neurodevelopmental retardation. Therefore, we recommend that valproic acid must be avoided during pregnancy, as new generation of anticonvulsant drugs have emerged into the market
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Fenótipo
/
Teratogênicos
/
Gravidez
/
Epilepsia Pós-Traumática
/
Deformidades Congênitas dos Membros
/
Craniossinostoses
/
Feto
/
Defeitos do Tubo Neural
Tipo de estudo:
Relato de Casos
Limite:
Feminino
/
Humanos
Idioma:
Inglês
Revista:
Saudi Med. J.
Ano de publicação:
2009
Similares
MEDLINE
...
LILACS
LIS